Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Abstract:
The investment was made by a syndicate of investors, including existing investor Mercia Technology Seed Fund, Advantage Enterprise & Innovation Fund (managed by Catapult Venture Managers) and a number of business angels.

Mills & Reeve helps nanoTherics Limited secure £1m investment: National law firm Mills & Reeve has advised successful technology company, nanoTherics Limited, in relation to a new investment round of over £1 million.

Cambridge, UK | Posted on May 30th, 2011

Corporate finance solicitor Pippa Pearce led the Mills & Reeve team representing the highly innovative life sciences company, which develops and commercialises innovative magnetic nanoparticle based products in the gene therapy research market.

nanoTherics was spun out from Keele University in 2007 following 30 years of combined leading edge research into the use of magnetic nanoparticles for biomedical applications conducted at Keele University and the University of Florida.

The company provides unique scientific devices and associated reagents designed to significantly improve uptake of biomaterials into cells, a process referred to as transfection, to greatly facilitate research into gene-related diseases and disorders. The company's mission is to become the leading supplier of intellectual property protected magnetic nanoparticle-based devices and consumables for transfection, providing superior performance products addressing a global market and underpinning the research and development of current and future drug and genetic screening and gene therapy programmes.

The investment took place on two tranches, with the first tranche completing in August 2010 and the second in January 2011. Dr Linda Cammish, CEO of nanoTherics said: "The funding has come at the appropriate time to allow nanoTherics to further develop its innovative technologies and products and improve research into genetic disease disorders, from Alzheimer's to cancer. This investment represents a critical point in the company's growth strategy and will enable us to place additional resources into the commercialism of our products."

Dr Mark Payton, Fund Principal at Mercia added: "We're delighted to continue to support nanoTherics in the development of its scalable and disruptive products and look forward to the next exciting step in the company's growth plan." He went on to say: "Mills & Reeve's venture capital team provided vital support in helping us complete this round - their experience and expertise in advising on sometimes complex syndicated investments in early stage and developing high-tech businesses was invaluable."

Pippa Pearce was assisted on the transaction by corporate lawyers, Dona Ardeman and Danielle Gibson and technology solicitor Nicola Kenward. Pippa commented: "We are pleased to have been able to assist this ambitious technology company raise the finance needed to ramp up commercialisation of its exciting products. We will follow their progress with interest."

Advantage Enterprise & Innovation Fund were advised by West Midlands firm George Green, led by partner Guy Green and assisted by Philip Round.

####

About Cambridge Network
With offices located in Cambridge, Norwich, Birmingham, Leeds, Manchester and London, Mills & Reeve is one of the UK's largest law firms, offering the full range of corporate and commercial services.

Our Cambridge office includes a specialist IP team dedicated to advising the region's technology companies and we have a close working relationship with Trask Britt, a specialist intellectual property firm based in the US.

We have over 80 qualified lawyers operating from our Norwich and Cambridge offices; with 23 partners leading teams in commercial, tax, banking, corporate finance, pensions, disputes and regulatory matters, with a specific focus on technology-based companies, advising on IP/IT, environmental, health and safety and related property issues.

We were also selected as one of the top three firms by The Lawyer magazine's prestigious 'Law Firm of the Year Award', Mills & Reeve was listed in the Sunday Times '100 Best Companies to Work For' for the seventh year running.

For more information, please click here

Contacts:
Francis House, 112 Hills Road, Cambridge
Postcode: CB2 1PH
United Kingdom
Tel: 44 01223 364422
Fax: 44 01223 355848

www.mills-reeve.com/

Copyright © Cambridge Network

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Immune system is key ally in cyberwar against cancer: Rice University study yields new two-step strategy for weakening cancer September 23rd, 2014

Los Alamos Researchers Uncover New Properties in Nanocomposite Oxide Ceramics for Reactor Fuel, Fast-Ion Conductors: Misfit dislocations are key to transport properties across material interfaces September 23rd, 2014

Production of Organometallic Frameworks in Least Possible Time September 23rd, 2014

Engineers show light can play seesaw at the nanoscale: Discovery is another step toward faster and more energy-efficient optical devices for computation and communication September 22nd, 2014

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Harris & Harris Group Letter to Shareholders on Website August 19th, 2014

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014

SouthWest NanoTechnologies Inc. Announces $2.7 Million in New Financing to Fund Growth, Plant Expansion and Technical Personnel August 11th, 2014

Harris & Harris Group Reports Financial Statements as of June 30, 2014 August 10th, 2014

Nanomedicine

Immune system is key ally in cyberwar against cancer: Rice University study yields new two-step strategy for weakening cancer September 23rd, 2014

Production of Organometallic Frameworks in Least Possible Time September 23rd, 2014

Engineered proteins stick like glue — even in water: New adhesives based on mussel proteins could be useful for naval or medical applications September 22nd, 2014

New chip promising for tumor-targeting research September 22nd, 2014

Announcements

Immune system is key ally in cyberwar against cancer: Rice University study yields new two-step strategy for weakening cancer September 23rd, 2014

Los Alamos Researchers Uncover New Properties in Nanocomposite Oxide Ceramics for Reactor Fuel, Fast-Ion Conductors: Misfit dislocations are key to transport properties across material interfaces September 23rd, 2014

Production of Organometallic Frameworks in Least Possible Time September 23rd, 2014

New star-shaped molecule breakthrough: Scientists at The University of Manchester have generated a new star-shaped molecule made up of interlocking rings, which is the most complex of its kind ever created September 22nd, 2014

Tools

IEEE International Electron Devices Meeting To Celebrate 60th Anniversary as The Leading Technical Conference for Advanced Semiconductor Devices September 18th, 2014

FEI Opens New Technology Center in Czech Republic: FEI expands its presence in Brno with the opening of a new, larger facility September 18th, 2014

New NPZ100-403 Piezo Stage from nPoint Inc. September 17th, 2014

Researchers Create World’s Largest DNA Origami September 11th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE